As the December 29, 2023 deadline for certain aspects of the Modernization of Cosmetics Regulation Act (“MoCRA”) approaches, FDA has finalized its guidance document governing the.
On December 14, 2023, FDA published updated instructions for reporting serious adverse events for cosmetic products, as mandated by the Modernization of Cosmetics Regulation Act of 2022 (MoCRA).
It’s been a busy week for the US Food & Drug Administration, with the Agency publishing, issuing, launching, and releasing a raft of MoCRA-related updates.